Lv12
20 积分 2026-04-01 加入
The Predictive Effect of the Systemic Immune-Inflammation Index for Patients with Small-Cell Lung Cancer
2小时前
已完结
The Predictive Effect of the Systemic Immune-Inflammation Index for Patients with Small-Cell Lung Cancer
2小时前
已关闭
The Predictive Effect of the Systemic Immune-Inflammation Index for Patients with Small-Cell Lung Cancer
2小时前
已关闭
Prognostic value of inflammatory response biomarkers using peripheral blood and [18F]-FDG PET/CT in advanced NSCLC patients treated with first-line chemo- or immunotherapy
6小时前
已完结
Association of Brain Metastases With Survival in Patients With Limited or Stable Extracranial Disease
14天前
已完结
Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial
17天前
已完结
Interim survival analysis of the randomized phase III GEMSTONE-302 trial: sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
18天前
已完结
皖公网安备34019202002308
